Estrella Immunopharma, Inc. (ESLA)
1.58
-0.13
(-7.60%)
USD |
NASDAQ |
Apr 24, 16:00
1.60
+0.02
(+1.27%)
After-Hours: 20:00
Estrella Immunopharma Total Assets (Quarterly) : 3.177M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 59.02B |
| Arcellx, Inc. | 603.99M |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Agenus, Inc. | 226.80M |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.54M |
| Shareholders Equity (Quarterly) | -10.37M |
| Current Ratio | 0.1238 |